table of content
1 Study Coverage
1.1 Human Rabies Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Human Rabies Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Vero Cell Rabies Vaccine
1.2.3 BHK
1.2.4 Chick Embryo Cell Rabies Vaccine
1.2.5 Others
1.3 Market by Application
1.3.1 Global Human Rabies Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pre-Exposure Prophylaxis
1.3.3 Post-Exposure Prophylaxis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Rabies Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Human Rabies Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Human Rabies Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Human Rabies Vaccines Sales by Region
2.4.1 Global Human Rabies Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Human Rabies Vaccines by Region (2023-2028)
2.5 Global Human Rabies Vaccines Revenue by Region
2.5.1 Global Human Rabies Vaccines Revenue by Region (2017-2022)
2.5.2 Global Human Rabies Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Rabies Vaccines Sales by Manufacturers
3.1.1 Global Top Human Rabies Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Human Rabies Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Rabies Vaccines in 2021
3.2 Global Human Rabies Vaccines Revenue by Manufacturers
3.2.1 Global Human Rabies Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Human Rabies Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Human Rabies Vaccines Revenue in 2021
3.3 Global Human Rabies Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Rabies Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Rabies Vaccines Sales by Type
4.1.1 Global Human Rabies Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Human Rabies Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Human Rabies Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Human Rabies Vaccines Revenue by Type
4.2.1 Global Human Rabies Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Human Rabies Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Human Rabies Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Human Rabies Vaccines Price by Type
4.3.1 Global Human Rabies Vaccines Price by Type (2017-2022)
4.3.2 Global Human Rabies Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Human Rabies Vaccines Sales by Application
5.1.1 Global Human Rabies Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Human Rabies Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Human Rabies Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Human Rabies Vaccines Revenue by Application
5.2.1 Global Human Rabies Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Human Rabies Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Human Rabies Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Human Rabies Vaccines Price by Application
5.3.1 Global Human Rabies Vaccines Price by Application (2017-2022)
5.3.2 Global Human Rabies Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Rabies Vaccines Market Size by Type
6.1.1 North America Human Rabies Vaccines Sales by Type (2017-2028)
6.1.2 North America Human Rabies Vaccines Revenue by Type (2017-2028)
6.2 North America Human Rabies Vaccines Market Size by Application
6.2.1 North America Human Rabies Vaccines Sales by Application (2017-2028)
6.2.2 North America Human Rabies Vaccines Revenue by Application (2017-2028)
6.3 North America Human Rabies Vaccines Market Size by Country
6.3.1 North America Human Rabies Vaccines Sales by Country (2017-2028)
6.3.2 North America Human Rabies Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Human Rabies Vaccines Market Size by Type
7.1.1 Europe Human Rabies Vaccines Sales by Type (2017-2028)
7.1.2 Europe Human Rabies Vaccines Revenue by Type (2017-2028)
7.2 Europe Human Rabies Vaccines Market Size by Application
7.2.1 Europe Human Rabies Vaccines Sales by Application (2017-2028)
7.2.2 Europe Human Rabies Vaccines Revenue by Application (2017-2028)
7.3 Europe Human Rabies Vaccines Market Size by Country
7.3.1 Europe Human Rabies Vaccines Sales by Country (2017-2028)
7.3.2 Europe Human Rabies Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Rabies Vaccines Market Size by Type
8.1.1 Asia Pacific Human Rabies Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Human Rabies Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Human Rabies Vaccines Market Size by Application
8.2.1 Asia Pacific Human Rabies Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Human Rabies Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Human Rabies Vaccines Market Size by Region
8.3.1 Asia Pacific Human Rabies Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Human Rabies Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Human Rabies Vaccines Market Size by Type
9.1.1 Latin America Human Rabies Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Human Rabies Vaccines Revenue by Type (2017-2028)
9.2 Latin America Human Rabies Vaccines Market Size by Application
9.2.1 Latin America Human Rabies Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Human Rabies Vaccines Revenue by Application (2017-2028)
9.3 Latin America Human Rabies Vaccines Market Size by Country
9.3.1 Latin America Human Rabies Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Human Rabies Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Rabies Vaccines Market Size by Type
10.1.1 Middle East and Africa Human Rabies Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Human Rabies Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Human Rabies Vaccines Market Size by Application
10.2.1 Middle East and Africa Human Rabies Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Human Rabies Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Human Rabies Vaccines Market Size by Country
10.3.1 Middle East and Africa Human Rabies Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Human Rabies Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi Pasteur?Inc.
11.1.1 Sanofi Pasteur?Inc. Corporation Information
11.1.2 Sanofi Pasteur?Inc. Overview
11.1.3 Sanofi Pasteur?Inc. Human Rabies Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Pasteur?Inc. Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Pasteur?Inc. Recent Developments
11.2 Novartis Vaccines and Diagnostics Ltd.
11.2.1 Novartis Vaccines and Diagnostics Ltd. Corporation Information
11.2.2 Novartis Vaccines and Diagnostics Ltd. Overview
11.2.3 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Vaccines and Diagnostics Ltd. Recent Developments
11.3 Cadila Pharmaceuticals Ltd.
11.3.1 Cadila Pharmaceuticals Ltd. Corporation Information
11.3.2 Cadila Pharmaceuticals Ltd. Overview
11.3.3 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cadila Pharmaceuticals Ltd. Recent Developments
11.4 GlaxoSmithKline Biologicals
11.4.1 GlaxoSmithKline Biologicals Corporation Information
11.4.2 GlaxoSmithKline Biologicals Overview
11.4.3 GlaxoSmithKline Biologicals Human Rabies Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GlaxoSmithKline Biologicals Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Biologicals Recent Developments
11.5 Merck?Co Inc.
11.5.1 Merck?Co Inc. Corporation Information
11.5.2 Merck?Co Inc. Overview
11.5.3 Merck?Co Inc. Human Rabies Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merck?Co Inc. Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck?Co Inc. Recent Developments
11.6 Wyeth pharmaceuticals
11.6.1 Wyeth pharmaceuticals Corporation Information
11.6.2 Wyeth pharmaceuticals Overview
11.6.3 Wyeth pharmaceuticals Human Rabies Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Wyeth pharmaceuticals Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Wyeth pharmaceuticals Recent Developments
11.7 Berna Biotech Ltd.
11.7.1 Berna Biotech Ltd. Corporation Information
11.7.2 Berna Biotech Ltd. Overview
11.7.3 Berna Biotech Ltd. Human Rabies Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Berna Biotech Ltd. Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Berna Biotech Ltd. Recent Developments
11.8 Medimmune LLC
11.8.1 Medimmune LLC Corporation Information
11.8.2 Medimmune LLC Overview
11.8.3 Medimmune LLC Human Rabies Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Medimmune LLC Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Medimmune LLC Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Rabies Vaccines Industry Chain Analysis
12.2 Human Rabies Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Rabies Vaccines Production Mode & Process
12.4 Human Rabies Vaccines Sales and Marketing
12.4.1 Human Rabies Vaccines Sales Channels
12.4.2 Human Rabies Vaccines Distributors
12.5 Human Rabies Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Rabies Vaccines Industry Trends
13.2 Human Rabies Vaccines Market Drivers
13.3 Human Rabies Vaccines Market Challenges
13.4 Human Rabies Vaccines Market Restraints
14 Key Findings in The Global Human Rabies Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
